A Comparison of Long-term Outcomes by Donor Type in the Era of Post-transplantation Cyclophosphamide for Aggressive Adult T-cell Leukemia/lymphoma
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Bazarbachi A, Reef D, Narvel H, Patel R, Al Hamed R, Vikash S
. Outcome of Stem Cell Transplantation in HTLV-1-Associated North American Adult T-Cell Leukemia/Lymphoma. Clin Hematol Int. 2023; 5(2-3):78-91.
PMC: 10241770.
DOI: 10.1007/s44228-023-00032-y.
View
2.
Utsunomiya A
. Progress in Allogeneic Hematopoietic Cell Transplantation in Adult T-Cell Leukemia-Lymphoma. Front Microbiol. 2019; 10:2235.
PMC: 6797831.
DOI: 10.3389/fmicb.2019.02235.
View
3.
Nosaka K, Iwanaga M, Imaizumi Y, Ishitsuka K, Ishizawa K, Ishida Y
. Epidemiological and clinical features of adult T-cell leukemia-lymphoma in Japan, 2010-2011: A nationwide survey. Cancer Sci. 2017; 108(12):2478-2486.
PMC: 5715256.
DOI: 10.1111/cas.13398.
View
4.
Tanaka T, Nakamae H, Ito A, Fuji S, Hirose A, Eto T
. A Phase I/II Multicenter Trial of HLA-Haploidentical PBSCT with PTCy for Aggressive Adult T Cell Leukemia/Lymphoma. Transplant Cell Ther. 2021; 27(11):928.e1-928.e7.
DOI: 10.1016/j.jtct.2021.07.010.
View
5.
Ito A, Nakano N, Tanaka T, Fuji S, Makiyama J, Inoue Y
. Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational study. Blood Adv. 2021; 5(20):4156-4166.
PMC: 8945611.
DOI: 10.1182/bloodadvances.2021004932.
View